Contact us
Menu
Contact us

Feldan News

Feldan

Feldan

Recent Posts by Feldan:

on Jun 16,2020

Quebec City, Canada, June 16, 2020, Feldan Therapeutics, a biotechnology company focusing on the development of therapeutics based on its intracellular delivery technology, today announced the appointment of Dr. Robert …

Read Story

on Oct 28,2019

Dr. Paul McCray (University of Iowa) and Feldan Therapeutics enable protein and CRISPR nuclease delivery to cultured human well-differentiated airway epithelial cells and in vivo using the Feldan Shuttle technology …

Read Story

on Jun 14,2019

On June 13th 2019, Anges Québec celebrated its 10th anniversary as part of the annual Rendez-vous 2019, the event that brings together angel investors, portfolio companies, venture capital ecosystem players …

Read Story

on Jun 4,2019

Philadelphia, June 4th, 2019 – CQDM is pleased to announce that following their recent enrollment in the consortium, Amgen and Takeda will be joining the syndicate of pharma companies to …

Read Story

on Feb 8,2019

Feldan Therapeutics is proud to unveil its new corporate identity! This new visual highlights the company's commitment to the therapeutic development of the Feldan Shuttle technology, an innovation developed in-house …

Read Story

on Dec 5,2018

Congratulations to Francois-Thomas Michaud for winning the “Visionary Entrepreneur of the Year” Award given by the CCIQ Chambre de commerce et d’industrie de Québec. Congratulations to Feldan Therapeutics’s team for its contribution to the success …

Read Story

on Nov 27,2018

Québec City, Canada, November 27, 2018 – Feldan Therapeutics (hereafter “Feldan”), a preclinical biotechnology company specialized in the intracellular delivery of therapeutic proteins and peptides, has announced an investment of …

Read Story

on Oct 12,2018

Quebec City, Canada, October 12, 2018 – David Guay, Research Director of Feldan Therapeutics (hereafter “Feldan”) announced that his collaborator, Dr. Paul McCray from the University of Iowa Carver College …

Read Story

on Sep 18,2018

QUÉBEC CITY, Sept. 18, 2018 /CNW Telbec/ - Feldan Therapeutics (hereafter "Feldan") has announced the closing of a $12.5 millions Series A financing round led by GC (parent company of GC Pharma), with the …

Read Story

on Jun 27,2018

Seoul (South Korea) & Québec City (Canada) June 27, 2018 – GC LabCell (hereafter “GCLC”) and Feldan Therapeutics (hereafter “Feldan”) announced an agreement today granting GCLC exclusive rights to use …

Read Story